(June 12, 2020, 1:35 PM EDT) -- NEW HAVEN, Conn. — Fifty states and the District of Columbia on June 10 filed an antitrust complaint against 26 generic drug companies and 10 executives alleging that the defendants conspired to inflate generic drug prices, reduce competition and restrain trade for topical drugs (Connecticut, et al. v. Sandoz, Inc., et al., No. 20-802, D. Conn.)....